线:TP53MDS?

Sarah Skuli1, Andrew Matthews1, Martin Carroll1

  • 1Division of Hematology and Oncology, Department of Medicine, The University of Pennsylvania, Philadelphia, PA.

Seminars in hematology
|November 14, 2024
PubMed
概括

在TP53基因的突变加剧了骨髓状腺癌的结果,如骨髓发育综合征 (MDS) 和急性骨髓状腺白血病 (AML). 本综述强调TP53突变的MDS,探讨其独特的生物学和结果与野生型疾病相比.